Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) EBIT (2016 - 2025)

Bio-Techne (TECH) has 17 years of EBIT data on record, last reported at $54.5 million in Q4 2025.

  • For Q4 2025, EBIT rose 14.85% year-over-year to $54.5 million; the TTM value through Dec 2025 reached $117.0 million, down 41.58%, while the annual FY2025 figure was $102.3 million, 50.53% down from the prior year.
  • EBIT reached $54.5 million in Q4 2025 per TECH's latest filing, up from $47.7 million in the prior quarter.
  • Across five years, EBIT topped out at $94.5 million in Q2 2023 and bottomed at -$23.9 million in Q2 2025.
  • Average EBIT over 5 years is $57.2 million, with a median of $59.3 million recorded in 2021.
  • Peak YoY movement for EBIT: soared 74.46% in 2021, then crashed 152.07% in 2025.
  • A 5-year view of EBIT shows it stood at $62.3 million in 2021, then rose by 8.89% to $67.9 million in 2022, then tumbled by 44.02% to $38.0 million in 2023, then grew by 24.77% to $47.4 million in 2024, then increased by 14.85% to $54.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were $54.5 million in Q4 2025, $47.7 million in Q3 2025, and -$23.9 million in Q2 2025.